Not all melanomas are created equal: a review and call for more research into nodular melanoma

Among the histogenic subtypes of melanoma, nodular melanoma (NM) is the major contributor for thicker and fatal melanomas and it has been associated with melanoma‐specific death in thin tumours, highlighting an important subgroup of ‘aggressive thin’ melanomas. This review provides a synthesis of the distinct characteristics of NM, with respect to epidemiology and risk factors, clinical presentation, histopathology, molecular and dermoscopic aspects, and screening practices. The real challenges are to find better biomarkers of aggressiveness and to know whether the control of such aggressive melanomas can be influenced by targeted interventions such as early detection, drug interventions and preventive strategies.

[1]  C. Longo,et al.  In vivo microscopic features of nodular melanomas: dermoscopy, confocal microscopy, and histopathologic correlates. , 2008, Archives of dermatology.

[2]  Josep Malvehy,et al.  Historical, clinical, and dermoscopic characteristics of thin nodular melanoma. , 2010, Archives of dermatology.

[3]  Victor G Prieto,et al.  Protocol for the examination of specimens from patients with melanoma of the skin. , 2009, Archives of pathology & laboratory medicine.

[4]  Stephen W Dusza,et al.  Melanoma Thickness and Survival Trends in the United States, 1989 to 2009. , 2016, Journal of the National Cancer Institute.

[5]  J. Aitken,et al.  Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  I. Zalaudek,et al.  Improving the early diagnosis of early nodular melanoma: can we do better? , 2018, Expert review of anticancer therapy.

[7]  P. Carli,et al.  Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. , 2003, Archives of dermatology.

[8]  J. Choi,et al.  Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta‐analysis , 2011, The British journal of dermatology.

[9]  Y. Fujisawa,et al.  Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma , 2019, Cancer medicine.

[10]  H. Cabo,et al.  Dermatoscopic features of thin (≤2 mm Breslow thickness) vs. thick (>2 mm Breslow thickness) nodular melanoma and predictors of nodular melanoma versus nodular non‐melanoma tumours: a multicentric collaborative study by the International Dermoscopy Society , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  B. Bastian,et al.  From melanocytes to melanomas , 2016, Nature Reviews Cancer.

[12]  J. Adler Nodular melanoma. , 1979, The American Journal of dermatopathology.

[13]  J. Kelly Nodular melanoma: how current approaches to early detection are failing. , 2005, Journal of Drugs in Dermatology.

[14]  S. Swetter,et al.  Factors related to the presentation of thin and thick nodular melanoma from a population‐based cancer registry in Queensland Australia , 2009, Cancer.

[15]  D. Elder,et al.  The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. , 2020, Archives of pathology & laboratory medicine.

[16]  I Zalaudek,et al.  Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study of 140 cases , 2013, The British journal of dermatology.

[17]  D. Sasseville,et al.  Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study. , 2019, Journal of the American Academy of Dermatology.

[18]  S. Swetter,et al.  Behavioral determinants of successful early melanoma detection , 2012, Cancer.

[19]  A. Halpern,et al.  Patterns of detection in patients with cutaneous melanoma , 2000, Cancer.

[20]  R. Wolfe,et al.  Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival , 2018, Journal of American Academy of Dermatology.

[21]  C. Balch,et al.  Identifying early melanomas at higher risk for metastases. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Scolyer,et al.  Data Set for Pathology Reporting of Cutaneous Invasive Melanoma , 2013, The American journal of surgical pathology.

[23]  David C Whiteman,et al.  The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin , 2011, Pigment cell & melanoma research.

[24]  J. Grob,et al.  The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. , 1998, Archives of dermatology.

[25]  H. Karim-Kos,et al.  Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  Shannon C. Trotter,et al.  Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy , 2017, Melanoma management.

[27]  Susan M Swetter,et al.  Efficacy of Skin Self-Examination Practices for Early Melanoma Detection , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[28]  Paula R. Blasi,et al.  Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.

[29]  B. Mcavoy,et al.  Nodular melanoma. No longer as simple as ABC. , 2003, Australian family physician.

[30]  Blair H. Smith,et al.  Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility , 2020, Nature Genetics.

[31]  S. Gruber,et al.  Is physician detection associated with thinner melanomas? , 1999, JAMA.

[32]  Lin Fritschi,et al.  Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection. , 2003, Journal of the American Academy of Dermatology.

[33]  Myles G Cockburn,et al.  Increasing burden of melanoma in the United States. , 2009, The Journal of investigative dermatology.

[34]  G. Giles,et al.  Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. , 2002, Archives of dermatology.

[35]  R. Hofmann-Wellenhof,et al.  Melanoma recognition by a deep learning convolutional neural network-Performance in different melanoma subtypes and localisations. , 2020, European journal of cancer.

[36]  Rory Wolfe,et al.  Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. , 2006, Archives of dermatology.

[37]  P. V. van Diest,et al.  Subtyping Cutaneous Melanoma Matters , 2020, JNCI cancer spectrum.

[38]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[39]  G. Argenziano,et al.  Dermoscopy and in vivo confocal microscopy are complementary techniques for diagnosis of difficult amelanotic and light‐coloured skin lesions , 2016, The British journal of dermatology.

[40]  B K Armstrong,et al.  Melanoma of the skin. , 1984, British medical bulletin.

[41]  M. Weinstock,et al.  Melanoma thickness trends in the United States, 1988-2006. , 2010, The Journal of investigative dermatology.

[42]  D. Kivaranovic,et al.  The burden of malignant melanoma--lessons to be learned from Austria. , 2016, European journal of cancer.

[43]  Donald R. Miller,et al.  Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers. , 2016, JAMA dermatology.

[44]  R. Marais,et al.  Nodular Melanoma: A Histopathologic Entity? , 2018, Acta dermato-venereologica.

[45]  K. Shannon,et al.  Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system , 2020, Cancer.

[46]  J. Bowling,et al.  Dermoscopic evaluation of nodular melanoma. , 2013, JAMA dermatology.

[47]  G. Moynihan The 3 Cs of melanoma: time for a change? , 1994, Journal of the American Academy of Dermatology.

[48]  M. Weinstock,et al.  Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[49]  Tumaini R. Coker,et al.  Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement. , 2023, JAMA.

[50]  M. Weinstock,et al.  The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. , 2012, Archives of dermatology.

[51]  E. Coups,et al.  Skin self-examination behaviors among individuals diagnosed with melanoma , 2016, Melanoma research.

[52]  L. Akslen,et al.  BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival , 2016, British Journal of Cancer.

[53]  P. Lorigan,et al.  Survival of patients with early invasive melanoma down‐staged under the new eighth edition of the American Joint Committee on Cancer staging system , 2019, Journal of American Academy of Dermatology.

[54]  D. Whiteman,et al.  The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031. , 2016, The Journal of investigative dermatology.

[55]  S. Dalton,et al.  Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases. , 2015, JAMA dermatology.

[56]  R. Scolyer,et al.  Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond , 2018, Annals of Surgical Oncology.

[57]  T. Kirchhoff,et al.  Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy , 2018, Journal of the National Cancer Institute.

[58]  A. Gavin,et al.  Trends in incidence of thick, thin and in situ melanoma in Europe. , 2018, European journal of cancer.

[59]  Chyke A Doubeni,et al.  Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.

[60]  D. Polsky,et al.  De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. , 2016, Journal of the National Cancer Institute.

[61]  V. Mar,et al.  Differing trends in thickness and survival between nodular and non‐nodular primary cutaneous melanoma in Victoria, Australia , 2015, The Medical journal of Australia.

[62]  H. Soyer,et al.  Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma , 2019, The British journal of dermatology.

[63]  L. Palmer,et al.  The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study , 2014, The British journal of dermatology.

[64]  L. Akslen,et al.  High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry , 2018, Clinical epidemiology.

[65]  R. Wolfe,et al.  Characteristics and associations of high-mitotic-rate melanoma. , 2014, JAMA dermatology.

[66]  F. Sera,et al.  Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. , 2009, European journal of cancer.

[67]  Rajiv Kumar,et al.  Dysplastic vs. Common Naevus-associated vs. De novo Melanomas: An Observational Retrospective Study of 1,021 Patients. , 2018, Acta dermato-venereologica.

[68]  I. Osman,et al.  Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model , 2012, Melanoma research.

[69]  A. Lallas,et al.  European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. , 2022, European journal of cancer.

[70]  R. Scolyer,et al.  Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care , 2011, Molecular oncology.

[71]  R. Braun,et al.  Incidence trends and clinical–pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland , 2017, Melanoma research.

[72]  S. Swetter,et al.  Nevus Count Associations with Thinner Nodular or Superficial Spreading Melanoma. , 2019, Acta dermato-venereologica.

[73]  H. Storm,et al.  Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011. , 2015, Cancer epidemiology.

[74]  S. Swetter,et al.  Association of Skin Examination Behaviors and Thinner Nodular vs Superficial Spreading Melanoma at Diagnosis , 2018, JAMA dermatology.

[75]  A. Lallas,et al.  Management Rules to Detect Melanoma , 2013, Dermatology.

[76]  Michael P Schön,et al.  Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas. , 2016, JAMA dermatology.

[77]  Jeffrey E Gershenwald,et al.  Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[78]  Susan M Swetter,et al.  Focus on early detection to reduce melanoma deaths. , 2015, The Journal of investigative dermatology.

[79]  I. Zalaudek,et al.  Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers. , 2019, Journal of the National Cancer Institute.

[80]  J. Kantor,et al.  Routine dermatologist-performed full-body skin examination and early melanoma detection. , 2009, Archives of dermatology.

[81]  Carrie D. Patnode,et al.  Behavioral Counseling for Skin Cancer Prevention: Evidence Report and Systematic Review for the US Preventive Services Task Force , 2018, JAMA.

[82]  C. Ingvar,et al.  Invasive cutaneous malignant melanoma in Sweden, 1990–1999 , 2004, Cancer.

[83]  I Zalaudek,et al.  Blue‐black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma , 2011, The British journal of dermatology.

[84]  J. Malvehy,et al.  Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians , 2017, Melanoma research.

[85]  J. Malvehy,et al.  High nevus counts confer a favorable prognosis in melanoma patients , 2015, International journal of cancer.

[86]  D. Schadendorf,et al.  Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma? , 2018, The Lancet. Oncology.

[87]  D. English,et al.  Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia. , 2013, Journal of the American Academy of Dermatology.

[88]  D. Whiteman,et al.  Anatomic site, sun exposure, and risk of cutaneous melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  M. Zappa,et al.  The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past , 2010, Melanoma research.

[90]  L. Wheless,et al.  Mitotic rate is associated with positive lymph nodes in patients with thin melanomas , 2017, Journal of the American Academy of Dermatology.

[91]  S. Rosso,et al.  Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study. , 2014, JAMA dermatology.

[92]  N. Hayward,et al.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.

[93]  A. Stromberg,et al.  Outcomes and prognostic factors in nodular melanomas. , 2012, Surgery.

[94]  Donald R. Miller,et al.  Early detection of thick melanomas in the United States: beware of the nodular subtype. , 2005, Archives of dermatology.

[95]  A. Gesierich,et al.  Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients , 2018, The British journal of dermatology.

[96]  R. Wolfe,et al.  Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus , 2017, The Medical journal of Australia.

[97]  A. Lallas,et al.  European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019. , 2020, European journal of cancer.

[98]  B. Glick Efficacy of Skin Self-Examination Practices for Early Melanoma Detection , 2011 .

[99]  D. Whiteman,et al.  Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study. , 2018, The Journal of investigative dermatology.